close 76% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 76% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Gesloten

SectorGezondheidszorg

18.57 3.22

Strong Buy

Prijsupdate 16 sep 2025, 19:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

17.96

Max

18.83

Belangrijke statistieken

By Trading Economics

Inkomsten

-14M

-101M

Verkoop

3K

75K

Winstmarge

-134,313.333

Werknemers

143

EBITDA

-14M

-100M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+105.25% upside

Dividenden

By Dow Jones

Volgende Winsten

11 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

242M

1.6B

Vorige openingsprijs

15.35

Vorige sluitingsprijs

18.57

Nieuwssentiment

By Acuity

23%

77%

65 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 sep 2025, 22:39 UTC

Acquisities, Fusies, Overnames

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

DJ

Lezen

15 sep 2025, 16:43 UTC

Belangrijke Marktbewegers

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

DJ

Lezen

15 sep 2025, 16:42 UTC

Belangrijke Marktbewegers

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

DJ

Lezen

15 sep 2025, 16:35 UTC

Belangrijke Marktbewegers

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

DJ

Lezen

15 sep 2025, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

15 sep 2025, 23:46 UTC

Marktinformatie

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

DJ

Lezen

15 sep 2025, 23:34 UTC

Marktinformatie

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

DJ

Lezen

15 sep 2025, 22:48 UTC

Marktinformatie

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

DJ

Lezen

15 sep 2025, 22:12 UTC

Acquisities, Fusies, Overnames

CSL Expects Commercial Launch in 2029

DJ

Lezen

15 sep 2025, 22:12 UTC

Acquisities, Fusies, Overnames

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

DJ

Lezen

15 sep 2025, 22:11 UTC

Acquisities, Fusies, Overnames

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

DJ

Lezen

15 sep 2025, 22:11 UTC

Acquisities, Fusies, Overnames

CSL to Have Right to Exercise Option Based on Phase 3 Data

DJ

Lezen

15 sep 2025, 22:10 UTC

Acquisities, Fusies, Overnames

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

DJ

Lezen

15 sep 2025, 21:16 UTC

Acquisities, Fusies, Overnames

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

DJ

Lezen

15 sep 2025, 21:16 UTC

Acquisities, Fusies, Overnames

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

DJ

Lezen

15 sep 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Chord Energy to Buy 48,000 Net Acres in the Williston Core

DJ

Lezen

15 sep 2025, 21:14 UTC

Acquisities, Fusies, Overnames

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

DJ

Lezen

15 sep 2025, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

DJ

Lezen

15 sep 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

15 sep 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

15 sep 2025, 19:29 UTC

Marktinformatie

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

DJ

Lezen

15 sep 2025, 19:14 UTC

Marktinformatie

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

DJ

Lezen

15 sep 2025, 18:16 UTC

Marktinformatie

Gold Powers to New High -- Market Talk

DJ

Lezen

15 sep 2025, 18:05 UTC

Marktinformatie

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

DJ

Lezen

15 sep 2025, 17:50 UTC

Acquisities, Fusies, Overnames

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

DJ

Lezen

15 sep 2025, 17:10 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

15 sep 2025, 17:10 UTC

Marktinformatie

S&P Expects Fed, BOC to Cut Rates -- Market Talk

DJ

Lezen

15 sep 2025, 16:52 UTC

Marktinformatie

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

DJ

Lezen

15 sep 2025, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

15 sep 2025, 16:20 UTC

Marktinformatie
Winsten

Auto & Transport Roundup: Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

105.25% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 38.73 USD  105.25%

Hoogste 50 USD

Laagste 26 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Gebaseerd op 12 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

65 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

764

↑ +2.13%

JNJ

Johnson and Johnson

176.45

↓-0.55%

ABBV

AbbVie Inc

216.08

↓-0.77%

UNH

UnitedHealth Group Inc

339.82

↓-2.33%

AZN

AstraZeneca PLC ADR

77.61

↓-0.58%
help-icon Live chat